ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
MacroGenics
The Scientist I/II will work in the Targeted Therapeutics Group to design, synthesize, characterize, and optimize antibody-drug conjugates, degrader‑antibody conjugates, and other targeted therapeutic modalities for cancer treatment. The role involves executing bioconjugation experiments, developing purification and analytical processes, and collaborating with cross‑functional teams to advance programs from discovery through preclinical and clinical development.
MacroGenics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies to improve the lives of cancer patients. The company is advancing a broad pipeline of novel product candidates spanning oncology, hematology, and autoimmune applications, including antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and T-cell engagers. MacroGenics has a proven track record of developing FDA-approved therapies in collaboration with global biopharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MacroGenics.
48% above the average for this role